Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

[1,8]Naphthyridine (CAS 254-60-4)

0.0(0)
Write a reviewAsk a question

CAS Number:
254-60-4
Purity:
≥97%
Molecular Weight:
130.15
Molecular Formula:
C8H6N2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

[1,8]Naphthyridine, an organic heterocyclic compound, possesses a distinctive five-membered ring structure comprising two nitrogen atoms and three carbon atoms. While it occurs naturally in various plants, it is also artificially synthesized in laboratory applications. In the realm of scientific research, [1,8]Naphthyridine has found extensive use across multiple disciplines, including medicinal chemistry, organic synthesis, and biochemistry. Medicinal chemists employ this compound to create diverse derivatives, including inhibitors of the enzyme cyclooxygenase-2 (COX-2). Its value in organic synthesis is evident as it serves as a key building block for synthesizing heterocyclic compounds like pyridines, quinolines, and indoles. Additionally, biochemists leverage [1,8]Naphthyridine to investigate enzyme structure, functionality, and the intricate interactions between enzymes and substrates. While the precise mechanism of action of [1,8]Naphthyridine remains partially understood, it is believed that the compound forms a complex with the targeted enzyme, leading to subsequent enzyme inhibition. This inhibition is thought to arise from the establishment of a covalent bond between the enzyme and [1,8]Naphthyridine, thus modulating the enzyme′s activity and functionality.


[1,8]Naphthyridine (CAS 254-60-4) References

  1. Tetrakis(mu(2)-1,8-naphthyridine)-1:2kappa(4)N:N';3:4kappa(4)N:N'-bis(mu(2)-salicylato)-1:4kappa(2)O:O';2:3kappa(2)O:O'-tetrakis(salicylic acid)-1kappaO,2kappaO,3kappaO,4kappaO-tetrasilver(I)(4 Ag-Ag).  |  Wang, Y. and Okabe, N. 2005. Acta Crystallogr C. 61: m263-5. PMID: 15930659
  2. 1,8-Naphthyridine derivatives as cholinesterases inhibitors and cell Ca2+ regulators, a multitarget strategy for Alzheimer's disease.  |  Egea, J. and de los Rios, C. 2011. Curr Top Med Chem. 11: 2807-23. PMID: 22039881
  3. 1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.  |  Madaan, A., et al. 2015. Arch Pharm (Weinheim). 348: 837-60. PMID: 26548568
  4. Synthesis of 2-cyclopropyl-3-(5-aryl-1H-pyrazol-3-yl)-1,8-naphthyridine.  |  Bucha, M., et al. 2014. Org Med Chem Lett. 4: 16. PMID: 26548992
  5. Ruthenium-Catalyzed Enantioselective Hydrogenation of 1,8-Naphthyridine Derivatives.  |  Ma, W., et al. 2016. Org Lett. 18: 2730-3. PMID: 27200456
  6. Synthesis and Biological Evaluation of Some Novel 1,8-Naphthyridine Derivatives.  |  Abu-Melha, S. 2017. Acta Chim Slov. 64: 919-930. PMID: 29318287
  7. Do 1,8-naphthyridine sulfonamides possess an inhibitory action against Tet(K) and MsrA efflux pumps in multiresistant Staphylococcus aureus strains?  |  Oliveira-Tintino, CDM., et al. 2020. Microb Pathog. 147: 104268. PMID: 32574783
  8. 1,8-Naphthyridine Derivatives: A Privileged Scaffold for Versatile Biological Activities.  |  Ojha, M., et al. 2021. Mini Rev Med Chem. 21: 586-601. PMID: 33038911
  9. The 1,8-naphthyridines sulfonamides are NorA efflux pump inhibitors.  |  Oliveira-Tintino, CDM., et al. 2021. J Glob Antimicrob Resist. 24: 233-240. PMID: 33385589
  10. Structural Characterization, Antimicrobial Activity and BSA/DNA Binding Affinity of New Silver(I) Complexes with Thianthrene and 1,8-Naphthyridine.  |  Ašanin, DP., et al. 2021. Molecules. 26: PMID: 33810316
  11. 1,8-naphthyridine derivatives: an updated review on recent advancements of their myriad biological activities.  |  Mithula, S., et al. 2021. Future Med Chem. 13: 1591-1618. PMID: 34256591
  12. Enhancement of Antibiotic Activity by 1,8-Naphthyridine Derivatives against Multi-Resistant Bacterial Strains.  |  Araújo-Neto, JB., et al. 2021. Molecules. 26: PMID: 34885981
  13. Synthesis, characterization, and in silico studies of 1,8-naphthyridine derivatives as potential anti-Parkinson's agents.  |  Ojha, M., et al. 2023. J Biomol Struct Dyn. 41: 805-820. PMID: 34895067

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

[1,8]Naphthyridine, 500 mg

sc-297968
500 mg
$202.00